5N Plus Inc. (TSE:VNP - Free Report) - Raymond James cut their Q3 2025 EPS estimates for shares of 5N Plus in a research report issued on Thursday, May 8th. Raymond James analyst M. Glen now forecasts that the company will post earnings of $0.08 per share for the quarter, down from their previous estimate of $0.11. The consensus estimate for 5N Plus' current full-year earnings is $0.37 per share. Raymond James also issued estimates for 5N Plus' Q4 2025 earnings at $0.08 EPS, FY2025 earnings at $0.42 EPS and FY2026 earnings at $0.49 EPS.
Separately, Cormark raised shares of 5N Plus to a "moderate buy" rating in a research report on Monday, April 21st. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, 5N Plus has an average rating of "Buy" and a consensus target price of C$8.60.
Check Out Our Latest Research Report on 5N Plus
5N Plus Price Performance
Shares of TSE VNP opened at C$7.73 on Monday. The company has a current ratio of 3.49, a quick ratio of 1.51 and a debt-to-equity ratio of 104.29. 5N Plus has a twelve month low of C$4.90 and a twelve month high of C$8.99. The stock has a 50 day moving average of C$5.85 and a two-hundred day moving average of C$6.68. The stock has a market cap of C$485.24 million, a P/E ratio of 30.39, a P/E/G ratio of 6,283.33 and a beta of 1.55.
Insider Activity at 5N Plus
In related news, Director Jean-Marie Bourassa sold 400,000 shares of 5N Plus stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of C$5.55, for a total value of C$2,220,000.00. 4.91% of the stock is currently owned by insiders.
About 5N Plus
(
Get Free Report)
5N Plus Inc produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider 5N Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 5N Plus wasn't on the list.
While 5N Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
